Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response

NCT03253081 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03253081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2018
Completion date
September 30, 2024
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children with autism